accepting new patients

M. Veronica Dioverti, M.D. is a Clinical Associate in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. She graduated from Universidad Nacional de Asuncion and completed her internship and residency training at Bridgeport Hospital-Yale University in Bridgeport, CT. She then pursued General and Transplant/Oncology Infectious Diseases fellowships at Mayo Clinic in Rochester, MN. Her primary clinical interest is caring for transplant, hematology/oncology malignancies and other immunocompromised patients. Her research has focused on optimizing the diagnosis of

Dr. Buckstein's research is clinical and focused on novel biological therapies for MDS and lymphomas. She is a clinician-investigator and interacts closely with the scientists of Sunnybrook Research Institute and elsewhere on collaborative projects

Dr. Brander focus on treating chronic lymphocytic leukemia (CLL). The way the CLL affects patients differs because leukemia can be different in different patients, and how it makes them feel can be very different. And, importantly, their goals of treatment are going to be very different. Dr. Brander would like patients to know that she understands that this is a new and different situation for them, and that this is as a partnership for the long haul. She also want them to know that she has compassion for what they are going through. Even though Dr. Brander sees a lot of CLL patients, she is

Dr. Mojtaba Akhtari is a Hematologist/Oncologist with medical and hematology/oncology training and experience in the United Kingdom and United States of America. He is board certified in Internal Medicine, Hematology and Medical Oncology. Currently he is working at Loma Linda Cancer Center and University Hospital. He is the Chief of Adult Hematopietic Stem Cell Transplant. He was also a member of adult bone marrow transplantation team at UNMC in Omaha, NE, and USC in Los Angeles, CA. His interests include malignant hematological disorders, particularly acute and chronic leukemias as well as